Cart is empty Mice infected with the bacteria that cause tuberculosis (TB) fared better when treated with an experimental compound that modulates immune responses than untreated mice did, according to a study led by Christina Stallings, a professor of molecular microbiology at Washington University in St. Louis (WashU) Medicine.
Leave A Comment